Page last updated: 2024-10-31

molsidomine and Hypertension, Renovascular

molsidomine has been researched along with Hypertension, Renovascular in 2 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Hypertension, Renovascular: Hypertension due to RENAL ARTERY OBSTRUCTION or compression.

Research Excerpts

ExcerptRelevanceReference
"We tested the hypothesis that increasing myocardial cyclic GMP levels would reduce myocardial O2 consumption and that renal hypertension (One Kidney-One Clip, 1K1C)-induced cardiac hypertrophy would change this relationship."7.69Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy. ( Naim, KL; Rabindranauth, P; Sadoff, JD; Scholz, PM; Tse, J; Weiss, HR, 1997)
"We tested the hypothesis that increasing myocardial cyclic GMP levels would reduce myocardial O2 consumption and that renal hypertension (One Kidney-One Clip, 1K1C)-induced cardiac hypertrophy would change this relationship."3.69Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy. ( Naim, KL; Rabindranauth, P; Sadoff, JD; Scholz, PM; Tse, J; Weiss, HR, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rabindranauth, P1
Naim, KL1
Scholz, PM1
Tse, J1
Sadoff, JD1
Weiss, HR1
Van de Voorde, J1
Claeys, M1
Leusen, I1

Other Studies

2 other studies available for molsidomine and Hypertension, Renovascular

ArticleYear
Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
    Basic research in cardiology, 1997, Volume: 92, Issue:1

    Topics: Animals; Blood Gas Analysis; Cardiomegaly; Coronary Circulation; Cyclic GMP; Enzyme Inhibitors; Guan

1997
Relaxations to endothelium-derived relaxing factor and the metabolite of molsidomine, SIN-1, in the aorta and the hindquarters of the rat.
    Journal of cardiovascular pharmacology, 1989, Volume: 14 Suppl 11

    Topics: Animals; Aorta; Aorta, Thoracic; Dose-Response Relationship, Drug; Drug Tolerance; Endothelium, Vasc

1989